{"id":708701,"date":"2026-08-17T11:36:03","date_gmt":"2026-08-17T11:36:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=708701"},"modified":"2026-08-17T11:36:03","modified_gmt":"2026-08-17T11:36:03","slug":"nestle-intentioneaza-sa-dezvolte-noi-produse-pentru-consumatorii-de-medicamente-pentru-slabit","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=708701","title":{"rendered":"Nestl\u00e9 inten\u021bioneaz\u0103 s\u0103 dezvolte noi produse pentru consumatorii de medicamente pentru sl\u0103bit"},"content":{"rendered":"<div class=\"sgb-google-buttons\">\n<div class=\"display-flex justify-center google-logo\"><img decoding=\"async\" loading=\"lazy\" class=\"mg-x-auto\" width=\"30\" height=\"30\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/08\/nestle-intentioneaza-sa-dezvolte-noi-produse-pentru-consumatorii-de-medicamente-pentru-slabit.png\" alt><\/div>\n<\/p><\/div>\n<p id=\"p-0\">Adoptarea rapid\u0103 a medicamentelor produse de Novo Nordisk \u0219i Eli Lilly a alimentat \u00eengrijor\u0103rile investitorilor c\u0103 medicamentele care suprim\u0103 apetitul ar putea reduce definitiv cererea de alimente ambalate, gust\u0103ri \u0219i b\u0103uturi, potrivit Reuters.<\/p>\n<p id=\"p-1\">Directorul tehnic al companiei Nestl\u00e9, Stefan Palzer, a declarat pentru <a href=\"https:\/\/www.reuters.com\/legal\/litigation\/nestle-looks-develop-new-products-serve-users-weight-loss-drugs-2026-08-17\/\" target=\"_blank\" rel=\"noopener\"><strong>Reuters<\/strong><\/a> c\u0103 gigantul&nbsp; utilizeaz\u0103 inteligen\u021ba artificial\u0103 \u0219i alte tehnologii pentru a analiza cercet\u0103rile clinice, a identifica combina\u021bii de nutrien\u021bi \u0219i a dezvolta produse adaptate utilizatorilor de GLP-1.<\/p>\n<p id=\"p-2\"><em>\u201eSuntem bine pozi\u021biona\u021bi cu acest portofoliu. Este o oportunitate uria\u0219\u0103 pentru compania noastr\u0103\u201d<\/em>, a afirmat declarat acesta.<\/p>\n<p id=\"p-3\">Compania utilizeaz\u0103 instrumente bazate pe inteligen\u021b\u0103 artificial\u0103 pentru a procesa volume mari de date din cercetarea clinic\u0103 \u0219i pentru a identifica combina\u021bii de nutrien\u021bi care ar putea contribui la men\u021binerea s\u0103n\u0103t\u0103\u021bii musculare, a hidrat\u0103rii \u0219i a aportului nutri\u021bional.<\/p>\n<p id=\"p-4\">Astfel, potrivit materialelor prezentate agen\u021biei, produsele ce urmeaz\u0103 s\u0103 fie dezvoltate ar putea contracara efecte secundare asociate cu medica\u021bia de pierdere \u00een greutate precum pierderea masei musculare \u0219i a gr\u0103simii de pe obraji.<\/p>\n<p id=\"p-5\"><em>\u201eAm descoperit o combina\u021bie de doi micronutrien\u021bi pe care am industrializat-o \u0219i care stimuleaz\u0103 cre\u0219terea \u021besutului muscular\u201d<\/em>, a declarat Stefan Palzer, Directorul Tehnic al Companiei.<\/p>\n<p id=\"p-6\">De asemenea, responsabilul companiei sus\u021bine c\u0103 Nestl\u00e9 a brevetat, de asemenea, combina\u021bii de ingrediente proprii, concepute pentru a reduce apetitul \u00een r\u00e2ndul consumatorilor care se confrunt\u0103 adesea cu o senza\u021bie de foame accentuat\u0103 dup\u0103 \u00eentreruperea tratamentelor cu GLP-1.<\/p>\n<p id=\"p-7\">Potrivit Boston Consulting Group, aproximativ 16 milioane de americani iau medicamente pe baz\u0103 de GLP-1, cifr\u0103 care se preconizeaz\u0103 c\u0103 va cre\u0219te semnificativ p\u00e2n\u0103 \u00een 2030.<\/p>\n<p id=\"p-8\">R\u0103spunsul companiei Nestl\u00e9 a constat \u00een dezvoltarea unor produse adaptate nevoilor cet\u0103\u021benilor care iau medicamente pentru sl\u0103bit, folosind \u00een acela\u0219i timp inteligen\u021ba artificial\u0103 pentru a accelera cercetarea, dezvoltarea produselor \u0219i analiza comportamentului consumatorilor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adoptarea rapid\u0103 a medicamentelor produse de Novo Nordisk \u0219i Eli Lilly a alimentat \u00eengrijor\u0103rile investitorilor c\u0103 medicamentele care suprim\u0103 apetitul ar putea reduce definitiv cererea de alimente ambalate, gust\u0103ri \u0219i &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=708701\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":708702,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/708701"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=708701"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/708701\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/708702"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=708701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=708701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=708701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}